title: Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma.
authors.affiliation: Division of Oncology, Washington University School of Medicine, St. Louis, MO.
authors.forename: Armin
authors.identifier: http://orcid.org/0000-0002-9384-272X
authors.initials: A
authors.lastname: Rashidi
authors.affiliation: Division of Oncology, Washington University School of Medicine, St. Louis, MO.
authors.forename: Eunhye
authors.initials: E
authors.lastname: Oak
authors.affiliation: Division of Oncology, Washington University School of Medicine, St. Louis, MO.
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Bartlett
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D060046:Maintenance Chemotherapy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab